Arran Turnbull Research Group

Research in a Nutshell

Our group aims to investigate the mechanisms of resistance to endocrine therapy and other treatments in breast cancer and develop clinically-applicable approaches to identify patients who are at higher risk of disease progression or relapse.

• Professor Charles Perou, University of North Carolina
• Professor Lisa Carey, University of North Carolina
• Professor Bob Clarke, Hormel Institute
• Professor Val Brunton, University of Edinburgh
• Professor Igor Goryanin, University of Edinburgh
• Professor David Cameron, University of Edinburgh
• Dr Tak Kitamura, University of Edinburgh
• Dr Olga Oikonomidou, University of Edinburgh
• Dr Peter Hall, Cancer Informatics, University of Edinburgh
• Astra Zeneca
• Genomic Health
• Philips
• InnoSIGN
• Digistain
• APIS Technologies
• Wobble Genomics
• Macromics

• Breast Cancer Now
• Breast Cancer Institute
• The Urology Foundation
• Royal Society of Edinburgh
• Tenovus Scotland
• CSO
• NHS Lothian Charity
• Len Thomson Trust
• John Black Foundation
• SULSA
• National Institute of Health (NIH) – Georgetown University